-
Sep 30, 2024 | 
european-biotechnology.com | Jeremy Levin |MB BChir |Thomas Gabrielczyk
The U.S. House of Representatives recently passed the BIOSECURE Act, which prohibits U.S. biopharma companies from collaborating with Chinese contractors. The Act, propelled by concerns about national security, including data leaks and intellectual property theft from U.S. companies, now moves to the Senate, where it is expected to pass. The impact is a ripple effect across the biopharmaceutical supply chain. U.S. companies will be forced to find alternative suppliers by January 2032.
-
Sep 1, 2024 | 
jacc.org | Jonathan Ariyaratnam |MB BChir |Melissa E Middeldorp |Anthony Brooks
ABSTRACTBackgroundThe coronary sinus (CS) is an arrhythmogenic structure which can initiate and maintain atrial fibrillation (AF). CS ablation has been shown to be effective in prolonging the AF cycle length and terminating AF in patients with both paroxysmal and persistent AF who have persistent AF after pulmonary vein isolation (PVI).
-
Aug 15, 2024 | 
hcplive.com | Nancy Reau |Palak J Trivedi |Gideon Hirschfield |MB BChir
In recognition of the US Food and Drug Administration accelerated approval of Gilead's seladelpar (Livdelzi) and other recent evolutions in primary biliary cholangitis (PBC), the latest HCPLive Special Report spotlights a conversation between a trio of subject matter experts on the latest advancements in PBC and their implications for disease management.
-
Jul 1, 2024 | 
jacc.org | Jonathan Ariyaratnam |MB BChir |Adrian D Elliott |Ricardo S. Mishima
References1. "Atrial remodeling and atrial fibrillation: recent advances and translational perspectives". J Am Coll Cardiol . 2014;63:22: 2335-2345. 2. "Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease". J Cardiovasc Electrophysiol . 2012;23:3: 232-238. 3. "Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse events". Stroke . 2018;49:10: 2301-2308. 4.
-
Apr 30, 2024 | 
healio.com | Cory Perla |Gideon Hirschfield |MB BChir |Heather Biele
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The liver’s production of bile acids is interwoven with the gut’s diverse microbial community. Despite treatment advances, the microbiome’s impact poses challenges in developing personalized therapies.
-
Mar 28, 2024 | 
the-rheumatologist.org | Mrinalini Dey |MB BChir |MA Cantab |Dip LCM
London to Orlando—Insights from Across the PondIn April 2023, fresh from a British Society for Rheumatology conference and clutching my poster tube (for the first time since the pandemic), I boarded a plane for a 10-hour flight from the U.K. to Orlando. Surrounded by families excited at the prospect of meeting Mickey Mouse, I took great joy in sharing my own excitement with intrigued passengers and flight attendants, who asked me about the contents of my poster tube and where I was heading.
-
Mar 6, 2024 | 
jacc.org | Xue Wang |MB BChir |Mohsin Gondal |Samer Alabed
IntroductionA 38-year-old woman was referred to the cardiology clinic with a 2-month history of mild exertional dyspnea along with sharp left subscapular and axillary pain unrelated to exertion. There was no significant past medical history or family history. Vital signs, physical examination, 12-lead electrocardiogram, and laboratory tests including N-terminal pro–B-type natriuretic peptide were normal. Chest x-ray showed cardiomegaly with an increased cardiothoracic ratio of 0.63.
-
Jan 26, 2024 | 
journals.healio.com | Thomas Weatherby |MB BChir |Ian Marsh |MB ChB
1.. The surgical management of exodeviations. Am J Ophthalmol. 1965; 59:603–620. > Crossref MedlineGoogle Scholar2.. Treatment of intermittent exotropia of the convergence insufficiency type with bupivacaine 0.75%: 5-year experience and outcomes. J Binocul Vis Ocul Motil. 2019; 69(1):3–7. doi:10.1080/2576117X.2018.1554930 > Crossref MedlineGoogle Scholar3.. Surgical outcomes of three different surgical techniques for treatment of convergence insufficiency intermittent exotropia. Eye (Lond).
-
Jan 1, 2024 | 
jacc.org | Antonides C.F.J |Eduard Rodenas-Alesina |Darshan H Brahmbhatt |MB BChir
References1. "Twelfth interagency registry for mechanically assisted circulatory support report: readmissions after left ventricular assist device". Ann Thorac Surg . 2022;113:3: 722-737. 2. "Analysis of trends and outcomes of 90 and 180 day readmissions after left ventricular assist device implantation". ASAIO J . 2022;68:3: 356-363. 3. "Evolution of late right heart failure with left ventricular assist devices and association with outcomes". J Am Coll Cardiol . 2021;78:23: 2294-2308. 4.
-
Oct 9, 2023 | 
medscape.com | Heather Payne |MB BChir
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Prescribing Information for NUBEQA®▼ (darolutamide) can be found here, and Xofigo®▼ (radium-223 dichloride) can be found here. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search MHRA Yellow Card in Google Play or Apple App Store.
